Cinzia Mortarino

Prof. Cinzia Mortarino

Università di Padova

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2013 in IMA Journal of Management Mathematics
Verified
Journal Article
Open access
PDF file
RGRenato Guseo
Renato Guseo
Cinzia MortarinoCinzia Mortarino
Cinzia Mortarino
Competition between rival brands within the same category gives rise to special competition/substitution effects of great interest to involved firms. In homogeneous product categories, the model structure should allow distinguishing between within-brand and cross-brand word-of-mouth effects. In this paper, we propose a model that, besides separating these two imitative sources, also allows for a change in the parameter values of the first entrant as soon as the second one enters the market. We prove that our model has a closed-form solution, allowing parameters to be estimated with sales data. Moreover, we compare our model with other unbalanced models, both from a theoretical point of view and from an empirical one, by assessing their performance on pharmaceutical drug data.

26 June 2009 in Quality and Reliability Engineering International
Verified
Journal Article
Closed access
PDF file
Cinzia MortarinoCinzia Mortarino
Cinzia Mortarino

4 January 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
Renato MillioniRenato Millioni
Renato Millioni
Cinzia MortarinoCinzia Mortarino
Cinzia Mortarino
Massive molecular testing for SARS-CoV-2 diagnosis is mandatory to manage the spread of COVID-19. Diagnostic screening should be performed at a mass scale, extended to the asymptomatic population, and repeated over time. An accurate diagnostic pipeline for SARS-CoV-2 that could massively increase the laboratory efficiency, while being sustainable in terms of time and costs, should be based on a pooling strategy. In the past few months, researchers from different disciplines had this same idea: test groups, not individuals. This critical review intends to highlight both the general consents—even if the results from different publications have been obtained with different protocols—and the points of disagreement that are creating some interpretative/comprehension difficulties. Different pooling schemes and technical aspects associated to the type of pooling adopted are described and discussed. We hope that this review can consolidate information to support researchers in designing optimized COVID-19 testing protocols based on pooling.

25 July 2012 in Statistics in Medicine
Verified
Journal Article
Closed access
PDF file
CFClaudia Furlan
Claudia Furlan
Cinzia MortarinoCinzia Mortarino
Cinzia Mortarino

1 October 2010 in Operations Research
Verified
Journal Article
Closed access
RGRenato Guseo
Renato Guseo
Cinzia MortarinoCinzia Mortarino
Cinzia Mortarino
The aim of this note is to correct an error in the formulation of Theorem 1 by Savin and Terwiesch [Savin, S., C. Terwiesch. 2005. Optimal product launch times in a duopoly: Balancing life-cycle revenues with product cost. Oper. Res. 53(1) 26–47]

30 December 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RMRenato Millioni
Renato Millioni
Cinzia MortarinoCinzia Mortarino
Cinzia Mortarino
The alarming spread of the pandemic coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus requires several measures to reduce the risk of contagion. Every successful strategy in controlling the SARS-CoV-2 infection depends on timely diagnosis, which should include testing of asymptomatic carriers. Consequently, increasing the throughput for clinical laboratories for the purposes of conducting large-scale diagnostic testing is urgently needed. Here we support the hypothesis that standard diagnostic protocol for SARS-CoV-2 virus could be conveniently applied to pooled samples obtained from different subjects. We suggest that a two-step sequential pooling procedure could identify positive subjects, ensuring at the same time significant benefits of cost and time. The simulation data presented herein were used to assess the efficiency, in terms of number of required tests, both for random assignment of the subjects to the pools and for situations in which epidemiological and clinical data are used to create "informed" pools. Different scenarios were simulated to measure the effect of different pool sizes and different values for virus frequency. Our results allow for a customization of the pooling strategy according to the specific characteristics of the cohort being tested.